48.07 (-%)
As of Dec 06, 2024
Source:
Revolution Medicines, Inc is a clinical-stage precision oncology company focused on developing targeted therapies to inhibit frontier targets in RAS-addicted cancers. We possess sophisticated structure-based drug discovery capabilities built upon deep chemical biology and cancer pharmacology know-how and innovative, proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites.
Country | United States |
Headquarters | redwood city, california |
Phone Number | (650) 481-6801 |
Industry | manufacturing |
CEO | Mark A. Goldsmith, M.D., Ph.D. |
Website | www.revmed.com |